Gilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...

Verizon has signed a 51,484-square-foot office lease at the Waterford Business District just south of Miami International ...

Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, ...

Investing.com -- Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ: GILD )' Lenacapavir (LEN) for HIV ...

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...

A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...

Wrestling sectionals were held over the weekend and Marion-area competitors earned berths into the upcoming district ...

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...

The winner plays for the championship Saturday at 4:30 p.m. at Mount Vernon Nazarene against either No. 4 Fairbanks or No. 5 ...

Salesforce is expected to report fourth-quarter results after the market closes Wednesday, with analysts largely bullish on the cloud-based software company's stock, anticipating AI-driven gains.

A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer. Working ...